Stamford, CT -- (SBWIRE) -- 09/30/2013 -- Jet Life Penny Stocks provides investors with the Best penny stock alerts on a regular basis. We will send you alerts through our Penny Stock Newsletters and offer you the tools to help you along the way with the goal of keeping you loyal to our service. Our today’s focus is on: Titan Pharmaceuticals, Inc.(OTCBB:TTNP), Applied DNA Sciences Inc(OTCMKTS:APDN) , Generex Biotechnology Corporation(OTCMKTS:GNBT), Sigma Labs Inc (OTCMKTS:SGLB)
Titan Pharmaceuticals, Inc.(OTCBB:TTNP) decreased -5.41% at the price of $0.663 recently on a traded volume of 477,316.00 shares, in comparison to 325,291.00 shares of average trading volume. So far this year, the stock is down over -35.68%.
The company has a total market capitalization of $54.69 million and its total outstanding shares are 82.54 million. Titan Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing proprietary therapeutics for the treatment of serious medical disorders in the United States.
Has TTNP Found The Bottom and Ready To Move Up? Find Out Here
Applied DNA Sciences Inc(OTCMKTS:APDN) soared 1.02% at the trading price of $0.0990 on a traded volume of 873,383.00 shares till now, whereas its average trading volume is 3.02 million shares. In the last three months, the stock is down -50.5%. The Intra-day range for the stock is $0.10and $0.10. Applied DNA Sciences, Inc. provides botanical-DNA based security and authentication solutions in Europe and the United States.
For How Long APDN Gloss will Attract Investors? Find out via this report
Generex Biotechnology Corporation(OTCMKTS:GNBT) dropped down -2.66% at the $0.0329 recently. So far in three months, the stock is up 1.23%. The 52-week range for the stock is $0.02 and $0.07. Its introductory price for the day was $0.03, with the overall traded volume of 1.72million shares. Generex Biotechnology Corporation, a development stage company, engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases
Why Should Investors Buy GNBT After the Recent Fall? Just Go Here and Find Out
Sigma Labs Inc (OTCMKTS:SGLB) after opening its shares at the price of $0.09, jumped up 2.63% , its recent trading price was $0.0975 for the day. The stock moved on a traded volume of 955,949.00 shares, in comparison to 3.18 million shares of average trading volume.
The 52-week range for the stock is $0.01 and $0.14. Its introductory price for the day was $0.09. Sigma Labs, Inc. engages in the development and commercialization of manufacturing and materials technologies, and R&D solutions. It also focuses on commercializing technologies and products in various industry sectors, such as in process quality assurance for manufacturing;
Why Should Investors Buy SGLB After The Recent Gain? Just Go Here and Find Out
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Jet Life Penny Stocks also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)